StockData
Viemed Healthcare, Inc. logo

Viemed Healthcare, Inc. (VMD) shareholders

VMDNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 18/3020% below fair value
$9.17+0.06 (+0.66%)

Close on Nov 13, 2026Market cap $349.27MP/E 24.1Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
71.3%
27M of 38M shares
Institutional holders
167
29 new, 11 sold out
Net institutional buying
2M
In Q2 2026
Insider trades, 12 months
0 buys · 9 sales
Net sold $1.59M

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Casey Hoyt
Joint filing with Elizabeth Rose Homes LLC (5.20%)
3,116,1898.00%13G (passive) amendmentDec 31, 2023
Kissel Edward Urban
Joint filing with Forager Capital Management, LLC (7.20%), Forager Fund, L.P. (7.20%) and 1 more
2,736,4727.20%13G (passive) amendmentSep 30, 2025
Thrivent Financial For Lutherans2,705,0006.80%13G (passive) amendmentMar 31, 2025
BlackRock Portfolio Management LLC2,540,1146.40%13G (passive)Jun 30, 2025
Michael Moore2,294,0185.90%13D (active) amendmentSep 24, 2026
BlackRock, Inc.2,278,6645.80%13G (passive) amendmentMar 31, 2025
MacArthur Robert Symmes
Joint filing with Forager Capital Management, LLC (5.50%), Forager Fund, L.P. (5.50%) and 1 more
2,186,4725.50%13G (passive)Jun 24, 2025

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of VMDValueChange% of portfolio
BlackRock, Inc.4,788,30712.57%$54.59M+165,7450.00%
Forager Capital Management, LLC2,141,1845.62%$24.41M−684,6879.18%
Vanguard Capital Management LLC1,321,6763.47%$15.07M+18,2920.00%
Nantahala Capital Management, LLC1,264,8903.32%$14.42M+381,1070.24%
Goldman Sachs Group Inc1,222,5343.21%$13.94M−199,1000.00%
First Eagle Investment Management, LLC1,070,3142.81%$12.20M+540,6570.01%
Ameriprise Financial Inc1,006,1952.64%$11.47M+107,8760.00%
Geode Capital Management, LLC973,7442.56%$11.10M+194,2220.00%
Raffles Associates LP807,3822.12%$9.20M+393,6914.04%
Arrowstreet Capital, Limited Partnership786,2692.06%$8.96M+75,0830.00%
State Street Corp762,0972.00%$8.69M+19,1380.00%
Panagora Asset Management Inc538,6251.41%$6.14M+66,5280.02%
Punch & Associates Investment Management, Inc.533,4661.40%$6.08M−3,8950.30%
Two Sigma Investments, LP438,8511.15%$5.00M+25,4570.00%
Renaissance Technologies LLC425,9001.12%$4.86M−16,3000.01%
Acadian Asset Management LLC398,5861.05%$4.54M+233,2990.01%
Creative Planning360,3560.95%$4.11M+139,9540.00%
Tocqueville Asset Management L.P.342,1000.90%$3.90M−130,0000.05%
Martin & Co Inc /Tn/340,7710.89%$3.88M+67,7700.61%
Bard Associates Inc339,6720.89%$3.87M−2690.86%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 202616727M71.3%29 / 7234 / 114M2M
Q1 202615025M65.3%32 / 5441 / 125M2M
Q4 202513224M63.0%20 / 4442 / 142M2M
Q3 202513125M64.6%13 / 4446 / 93M4M
Q2 202512726M67.3%11 / 6135 / 223M2M
Q1 202513925M65.3%11 / 5342 / 102M2M
Q4 202414125M66.4%30 / 4528 / 82M2M
Q3 202412125M66.4%22 / 4026 / 156M4M
Q2 202411627M70.6%19 / 5428 / 154M3M
Q1 202411225M66.7%21 / 3628 / 134M4M
Q4 202310425M66.8%12 / 3335 / 204M2M
Q3 202311224M61.8%20 / 3833 / 102M2M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

135 funds held VMD in Q2 2026, 43% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of VMDValue% of fundAs of
Vanguard Total Stock Market Index Fund912,7132.40%$10.40M0.00%Jun 30, 2026
iShares Russell 2000 ETF870,0452.28%$9.92M0.01%Jun 30, 2026
Columbia Small Cap Value Discovery Fund566,6301.49%$6.61M0.26%Jul 31, 2026
BlackRock Advantage Small Cap Core Fund485,2881.27%$4.78M0.09%May 29, 2026
First Eagle Small Cap Opportunity Fund467,3001.23%$5.45M0.19%Jul 31, 2026
Vanguard Extended Market Index Fund373,4590.98%$4.26M0.00%Jun 30, 2026
Fidelity Small Cap Index Fund372,2270.98%$4.34M0.01%Jul 31, 2026
iShares Russell 2000 Growth ETF319,9610.84%$3.65M0.02%Jun 30, 2026
Vanguard Russell 2000 Index Fund171,9490.45%$1.69M0.01%May 31, 2026
Fidelity Extended Market Index Fund170,7360.45%$1.68M0.00%May 31, 2026
BlackRock Advantage Small Cap Growth Fund124,6150.33%$1.42M0.17%Jun 30, 2026
iShares Micro-Cap ETF114,1290.30%$1.30M0.09%Jun 30, 2026
First Trust Dow Jones Select MicroCap Index Fund110,6940.29%$1.26M0.48%Jun 30, 2026
Columbia Variable Portfolio - Small Cap Value Discovery Fund102,5200.27%$1.17M0.26%Jun 30, 2026
Fidelity SAI Small-Mid Cap Momentum Index Fund101,0490.27%$1.18M0.03%Jul 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
William FrazierChief Medical Officer, Director83,2140.22%Jun 26, 2026
Casey HoytChief Executive Officer, Director2,349,3206.17%Feb 2, 2026
William Todd ZehnderChief Operating Officer, Director401,6771.05%Feb 2, 2026
Michael MoorePresident1,774,9024.66%Mar 20, 2026
Jeremy TrahanGeneral Counsel49,4310.13%Feb 2, 2026
Jerome CambreVice President of Sales106,4430.28%Feb 2, 2026
Trae FitzgeraldChief Financial Officer105,6380.28%Feb 2, 2026
Nitin KaushalDirector161,3610.42%Aug 19, 2026
Sabrina HeltzDirector82,5200.22%Aug 19, 2026
Randy E. DobbsDirector142,2530.37%Aug 19, 2026
Timothy SmokoffDirector94,3040.25%Aug 19, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Randy E. Dobbs
Director
Aug 19, 2026Returned to company−4,191$8.94$37.47K142,253
Randy E. Dobbs
Director
Aug 19, 2026Option exercise+4,191––146,444
Randy E. Dobbs
Director
Aug 19, 2026Option exercise+16,763––142,253
Timothy Smokoff
Director
Aug 19, 2026Option exercise+3,757––94,304
Timothy Smokoff
Director
Aug 19, 2026Returned to company−3,757$8.94$33.59K90,547
Timothy Smokoff
Director
Aug 19, 2026Option exercise+15,029––90,547
Nitin Kaushal
Director
Aug 19, 2026Option exercise+18,786––161,361
Sabrina Heltz
Director
Aug 19, 2026Returned to company−3,757$8.94$33.59K82,520
Sabrina Heltz
Director
Aug 19, 2026Option exercise+3,757––86,277
Sabrina Heltz
Director
Aug 19, 2026Option exercise+15,029––82,520
William Frazier
Chief Medical Officer, Director
Jun 25, 2026Option exercise+10,000$1.81$18.10K83,214
William Frazier
Chief Medical Officer, Director
Jun 25, 2026Sale−10,000$11.72$117.20K73,214
Timothy Smokoff
Director
Jun 24, 2026Sale−5,000$11.53$57.65K80,518
Timothy Smokoff
Director
Jun 24, 2026Sale−1,636$11.48$18.78K93,882
Timothy Smokoff
Director
Jun 24, 2026Sale−5,000$11.41$57.05K75,518
Timothy Smokoff
Director
Jun 24, 2026Sale−5,000$11.56$57.80K85,518
Timothy Smokoff
Director
Jun 24, 2026Sale−3,364$11.50$38.69K90,518
Michael Moore
President
Mar 20, 2026Sale−65,000$8.77$570.05K1,585,812
Michael Moore
President
Mar 19, 2026Sale−40,232$9.21$370.54K1,650,812
Michael Moore
President
Mar 18, 2026Sale−31,570$9.42$297.39K1,691,044
Jerome Cambre
Vice President of Sales
Jan 29, 2026Option exercise+8,619––106,443
Jerome Cambre
Vice President of Sales
Jan 29, 2026Tax withholding−2,355$7.48$17.62K104,088
Jerome Cambre
Vice President of Sales
Jan 29, 2026Option exercise+2,873––106,961
Jerome Cambre
Vice President of Sales
Jan 29, 2026Returned to company−2,873$7.48$21.49K104,088
Jeremy Trahan
General Counsel
Jan 29, 2026Option exercise+10,774––49,431
Jeremy Trahan
General Counsel
Jan 29, 2026Tax withholding−2,939$7.48$21.98K46,492
Jeremy Trahan
General Counsel
Jan 29, 2026Option exercise+3,591––50,083
Jeremy Trahan
General Counsel
Jan 29, 2026Returned to company−3,591$7.48$26.86K46,492
Michael Moore
President
Jan 29, 2026Tax withholding−7,342$7.48$54.92K189,090
Michael Moore
President
Jan 29, 2026Option exercise+26,842––196,432
Michael Moore
President
Jan 29, 2026Returned to company−8,947$7.48$66.92K189,090
Michael Moore
President
Jan 29, 2026Option exercise+8,947––198,037
Trae Fitzgerald
Chief Financial Officer
Jan 29, 2026Returned to company−3,265$7.48$24.42K105,638
Trae Fitzgerald
Chief Financial Officer
Jan 29, 2026Option exercise+9,794––108,317
Trae Fitzgerald
Chief Financial Officer
Jan 29, 2026Tax withholding−2,679$7.48$20.04K105,638
Trae Fitzgerald
Chief Financial Officer
Jan 29, 2026Option exercise+3,265––108,903
William Todd Zehnder
Chief Operating Officer, Director
Jan 29, 2026Option exercise+26,842––401,677
William Todd Zehnder
Chief Operating Officer, Director
Jan 29, 2026Tax withholding−11,368$7.48$85.03K390,309
William Todd Zehnder
Chief Operating Officer, Director
Jan 29, 2026Option exercise+8,948––399,257
William Todd Zehnder
Chief Operating Officer, Director
Jan 29, 2026Returned to company−8,948$7.48$66.93K390,309
William Frazier
Chief Medical Officer, Director
Jan 29, 2026Tax withholding−802$7.48$6.00K73,214
William Frazier
Chief Medical Officer, Director
Jan 29, 2026Option exercise+778––73,992
William Frazier
Chief Medical Officer, Director
Jan 29, 2026Returned to company−778$7.48$5.82K73,214
William Frazier
Chief Medical Officer, Director
Jan 29, 2026Option exercise+2,334––74,016
Casey Hoyt
Chief Executive Officer, Director
Jan 29, 2026Option exercise+39,795––364,377
Casey Hoyt
Chief Executive Officer, Director
Jan 29, 2026Tax withholding−13,913$7.48$104.07K350,464
Casey Hoyt
Chief Executive Officer, Director
Jan 29, 2026Option exercise+13,265––363,729
Casey Hoyt
Chief Executive Officer, Director
Jan 29, 2026Returned to company−13,265$7.48$99.22K350,464
Jerome Cambre
Vice President of Sales
Jan 21, 2026Option exercise+11,719––101,651
Jerome Cambre
Vice President of Sales
Jan 21, 2026Tax withholding−3,827$7.49$28.66K97,824
Jerome Cambre
Vice President of Sales
Jan 21, 2026Returned to company−2,930$7.49$21.95K97,824
Jerome Cambre
Vice President of Sales
Jan 21, 2026Option exercise+2,930––100,754
Casey Hoyt
Chief Executive Officer, Director
Jan 21, 2026Option exercise+12,400––336,982
Casey Hoyt
Chief Executive Officer, Director
Jan 21, 2026Tax withholding−13,565$7.49$101.60K324,582
Casey Hoyt
Chief Executive Officer, Director
Jan 21, 2026Returned to company−12,400$7.49$92.88K324,582
Casey Hoyt
Chief Executive Officer, Director
Jan 21, 2026Option exercise+49,597––338,147
Trae Fitzgerald
Chief Financial Officer
Jan 21, 2026Tax withholding−4,246$7.49$31.80K98,523
Trae Fitzgerald
Chief Financial Officer
Jan 21, 2026Option exercise+13,317––102,769
Trae Fitzgerald
Chief Financial Officer
Jan 21, 2026Returned to company−3,329$7.49$24.93K98,523
Trae Fitzgerald
Chief Financial Officer
Jan 21, 2026Option exercise+3,329––101,852

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
4.68%
2M shares short
Days to cover
8.5
At 0M shares a day
Change since last report
-1.7%
From 2M shares
Short volume, 20 days
48.9%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Viemed Healthcare's stock actually held short. Settlement fails (shares not delivered on time) peaked at 2,336 shares on Aug 28, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Moore Faster LLC
Officer
Mar 20, 202665,000$570.12KMar 20, 2026Merger/Acquisition
Moore Faster LLC
Officer
Mar 19, 202640,232$370.42KMar 19, 2026Merger/Acquisition
Moore Faster LLC
Officer
Mar 18, 202631,570$297.35KMar 18, 2026Merger/Acquisition

See a number that looks wrong?